Why Flexible Space Is Key In Getting Therapies To Market Faster

In the race to get new drugs from the research stages to pharmacy shelves, next generation lab space can be the catalyst for success. Reconfiguring pharmaceutical or biotech labs is becoming more accessible as life sciences companies move away from conventional lab design in favor of more flexible spaces that can keep up with the pace of innovation. These changes are arising as part of a wider shift toward shorter research and development timelines and the need to reduce costs.